Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03222752 · ClinicalTrials.gov registry record · NA
Efficacy of Cranial Electrotherapy Stimulation (CES) for the Treatment of Major Depressive Disorder
A NA study, sponsored by Electromedical Products International.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03222752: Clinical Trial NA study, sponsored by Electromedical Products International.
NCT03222752 is a NA study that was terminated before completion, run by Electromedical Products International. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03222752, a NA study, was terminated before completion, sponsored by Electromedical Products International.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Efficacy of Cranial Electrotherapy Stimulation (CES) for the treatment of Major Depressive Disorder
Primary Outcome
The Hamilton Rating Scale for Depression (HRSD), also called the Hamilton Depression Rating Scale (HDRS), abbreviated HAM-D, is a multiple item questionnaire used to provide an indication of depression, and as a guide to evaluate recovery.
Interventions
- DEVICE Cranial Electrotherapy Stimulation
- DEVICE Sham Cranial Electrotherapy Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-06-05 |
| Est. Completion | 2023-04-25 |
| Phase | NA |
Why NCT03222752 stopped before completion
NCT03222752 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Cranial Electrotherapy Stimulation is the first listed.
NCT03222752 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03222752 about?
NCT03222752 is a clinical study titled "Efficacy of Cranial Electrotherapy Stimulation (CES) for the Treatment of Major Depressive Disorder". Efficacy of Cranial Electrotherapy Stimulation (CES) for the treatment of Major Depressive Disorder
What is the current status of trial NCT03222752?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2017-06-05. Estimated completion is 2023-04-25.
What interventions are being tested in trial NCT03222752?
The interventions under investigation include: Cranial Electrotherapy Stimulation (DEVICE), Sham Cranial Electrotherapy Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03222752?
This trial is sponsored by Electromedical Products International, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03222752's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI